DK0496832T3 - Inhibering af PADGEM-formidlet cellebinding - Google Patents

Inhibering af PADGEM-formidlet cellebinding

Info

Publication number
DK0496832T3
DK0496832T3 DK90917479.9T DK90917479T DK0496832T3 DK 0496832 T3 DK0496832 T3 DK 0496832T3 DK 90917479 T DK90917479 T DK 90917479T DK 0496832 T3 DK0496832 T3 DK 0496832T3
Authority
DK
Denmark
Prior art keywords
padgem
inhibition
cell binding
mediated cell
cell
Prior art date
Application number
DK90917479.9T
Other languages
English (en)
Inventor
Barbara C Furie
Bruce Furie
Eric Larsen
Alessandro Celi
Gary E Gilbert
John K Erban
Roberta Bonfanti
Denisa D Wagner
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Application granted granted Critical
Publication of DK0496832T3 publication Critical patent/DK0496832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Networks Using Active Elements (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90917479.9T 1989-10-20 1990-10-22 Inhibering af PADGEM-formidlet cellebinding DK0496832T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42488689A 1989-10-20 1989-10-20

Publications (1)

Publication Number Publication Date
DK0496832T3 true DK0496832T3 (da) 1996-12-30

Family

ID=23684279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917479.9T DK0496832T3 (da) 1989-10-20 1990-10-22 Inhibering af PADGEM-formidlet cellebinding

Country Status (9)

Country Link
EP (1) EP0496832B1 (da)
JP (1) JPH05504470A (da)
AT (1) ATE146218T1 (da)
CA (1) CA2067250C (da)
DE (1) DE69029398T2 (da)
DK (1) DK0496832T3 (da)
ES (1) ES2097765T3 (da)
GR (1) GR3022011T3 (da)
WO (1) WO1991006632A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800815A (en) * 1903-05-05 1998-09-01 Cytel Corporation Antibodies to P-selectin and their uses
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5753631A (en) * 1990-06-15 1998-05-19 Cytel Corporation Intercellular adhesion mediators
CA2086323C (en) * 1990-07-17 2002-05-14 Rodger P. Mcever Functionally active selectin-derived peptides and ligand for gmp-140
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
EP0575557A1 (en) * 1991-03-11 1993-12-29 New England Medical Center Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
JPH07502011A (ja) * 1991-06-10 1995-03-02 グライカムド　インコーポレイテッド 免疫抑制性および寛容原性のオリゴ糖誘導体
US5646123A (en) * 1991-06-10 1997-07-08 Alberta Research Council Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
EP0608260A1 (en) * 1991-09-10 1994-08-03 Centocor, Inc. Peptide inhibitors of inflammation mediated by selectins
ATE169227T1 (de) * 1991-09-30 1998-08-15 Biogen Inc Hemmung von gefässverengung unter verwendung von anti-padgem antikörpern.
AU3914393A (en) * 1991-12-18 1994-03-15 Board Of Regents Of The University Of Oklahoma, The Peptide inhibitors of inflammation mediated by selectins
ATE237353T1 (de) * 1992-05-05 2003-05-15 Aeres Biomedical Ltd Antikörper gegen p-selectin und ihre verwendung
US6033667A (en) * 1992-05-05 2000-03-07 Cytel Corporation Method for detecting the presence of P-selectin
CA2135390A1 (en) * 1992-05-11 1993-11-25 Matthew Moyle Novel neutrophil inhibitors
EP0666914B1 (en) * 1992-10-23 2003-12-10 Genetics Institute, LLC Novel p-selectin ligand protein
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
EP0668907A1 (en) * 1992-11-16 1995-08-30 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for p-selectin and methods of use thereof
EP0804235A4 (en) * 1993-05-04 2001-09-19 Aeres Biomedical Ltd ANTIBODIES AGAINST SELECTIN P AND USES THEREOF
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
CA2086323C (en) * 1990-07-17 2002-05-14 Rodger P. Mcever Functionally active selectin-derived peptides and ligand for gmp-140

Also Published As

Publication number Publication date
ES2097765T3 (es) 1997-04-16
GR3022011T3 (en) 1997-03-31
EP0496832A1 (en) 1992-08-05
DE69029398D1 (de) 1997-01-23
WO1991006632A1 (en) 1991-05-16
EP0496832B1 (en) 1996-12-11
JPH05504470A (ja) 1993-07-15
EP0496832A4 (en) 1993-02-17
ATE146218T1 (de) 1996-12-15
DE69029398T2 (de) 1997-04-10
CA2067250A1 (en) 1991-04-21
CA2067250C (en) 2008-06-17

Similar Documents

Publication Publication Date Title
DK0496832T3 (da) Inhibering af PADGEM-formidlet cellebinding
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
DE59003021D1 (de) Gerät zur entnahme von bodenproben.
DE3671105D1 (de) Automatischer analysator mit freiem zugang zur probe.
DE68923389D1 (de) Detektorzelle für Flüssigkeitschromatographie.
DE3787771D1 (de) Elektrochemische Analysenmethode.
ES517080A0 (es) Procedimiento de inmunoanalisis para determinar una iodotironina en una muestra de analisis.
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
DE69119750D1 (de) Messzelle für chemische oder biochemische proben
BR9401570A (pt) Aparelhagem para detecção de microorganismos em amostras de espécime de fluido
DE3668378D1 (de) Verfahren zur hemmung der glycolyse in blutproben.
DE3854876D1 (de) Biochemisches Analysegerät.
ATE76508T1 (de) Vorrichtung zur feststellung von okkultem blut.
NO890867L (no) Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn.
ES542863A0 (es) Un aparato para la criofijacion de muestras.
NO864113D0 (no) Fremgangsmaate for immonoassay, samt analysesett for dens utfoerelse.
ES509142A0 (es) Procedimiento para determinar la presencia de una analito en una muestra sospechosa de contenerlo.
NO910202L (no) Fremgangsmaate for aa identifisere hydrokarbonfoerende lag iundergrunnsformasjoner.
DE3852227D1 (de) Immunologisches Nachweisverfahren für Herbizide.
DE3853560D1 (de) Analytisches Element zur Vollblutuntersuchung.
DE3750084D1 (de) Anordnung für Einführung von Vorrissen in Keramikproben.
DE69023426D1 (de) Behälter für Flüssigkeitsproben.
PT77153A (de) Drehzapfenlager fuer tueren insbesondere fuer pendeltueren
DK51485A (da) Immunanalyse til paavisning af analytter i biologiske proever
DE69007155D1 (de) Automatisierte Schnittentwicklungsanalyse von mehrfachen Proben.